Biochemical and Immunochemical Evidences Supporting the Inclusion of Quinoa (Chenopodium quinoa Willd.) as a Gluten-free Ingredient
- 855 Downloads
To date, the only acceptable therapeutic approach for celiac disease (CD) is a strict elimination from the diet of gluten-containing foods, but this diet does not always guarantee an adequate nutritional intake. Pseudocereals are receiving considerable attention as interesting alternatives for the formulation of gluten-free products, and quinoa grains arise as nutritive substitutes of conventional cereals. The aim of this study was the characterization of different quinoa samples corresponding to 11 quinoa varieties, using polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate (SDS-PAGE) and immunoblotting techniques to assess their suitability for celiac subjects. Some of these varieties were grown in Italy to assess if the reproduction in a new habitat can guarantee the retention of the “safe” protein pattern. None of the quinoa varieties studied presented protein bands with electrophoretic mobility comparable with those of wheat gliadins, the toxic protein for celiac subjects. All the quinoa samples showed a low binding affinity for both specific anti-gliadin antibodies and IgAs from celiac subjects, confirming that quinoa can be considered as a safe ingredient for celiac patients. However, reliable varieties should be previously selected since the immuno cross-reactivity with anti-gliadin antibodies can vary significantly.
KeywordsCeliac disease Quinoa Gluten-free SDS-PAGE Immunoblotting
Bromochloroindolyl phosphate-nitroblue tetrazolium
Polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate
This work was partially supported by the Flagship Project “Istituto dell’Alimentazione e della Salute”, Municipality of Milan. We would like to thank the following Donors for graciously providing us the Chenopodium quinoa samples studied: Hohenheim University, Germany; National Agricultural Research Foundation - Fodder Crops and Pasture Institute (NARF-FCPI), Greece; Bundesanstalt für Züchtungforschung an Kulturplanzen (BAZ), Germany; United States Department of Agriculture – North Central Regional Plant Introduction System (USDA-NCRPIS), USA.
Conflict of Interest
The authors claim no conflict of interest.
- 2.Catassi C, Fasano A (2008) Celiac disease. In: Arendt EK, Dal Bello F (eds) Gluten-free cereal products and beverages. Academic, LondonGoogle Scholar
- 6.Kinsey L, Burden ST, Bannerman EA (2008) Dietary survey to determine if patients with coeliac disease are meeting current healthy eating guidelines and how their diet compares to that of the British general population. Eur J Clin Nutr 62:1333–1342. doi: 10.1038/sj.ejcn.1602856 CrossRefGoogle Scholar
- 13.Ballabio C, Uberti F, Di Lorenzo C, Brandolini A, Peñas E, Restani P (2011) Biochemical and immunochemical characterization of different varieties of amaranth (Amaranthus L. spp) as a safe ingredient for gluten-free products. J Agric Food Chem 59:12969–12974. doi: 10.1021/jf2041824 CrossRefGoogle Scholar
- 17.Nascimento AC, Mota C, Coelho I, Gueifao S, Santos M, Matos AS, Gimenez A, Lobo M, Samman N, Castanheira I (2014) Characterisation of nutrient profile of quinoa (Chenopodium quinoa), amaranth (Amaranthus caudatus), and purple corn (Zea mays L.) consumed in the North of Argentina: proximates, minerals and trace elements. Food Chem 148:420–426. doi: 10.1016/j.foodchem.2013.09.155 CrossRefGoogle Scholar
- 18.Stikic R, Glamoclija D, Demin M, Vucelic-Radovic B, Jovanovic Z, Milojkovic-Opsenica D, Jacobsen S-E, Milovanovic M (2012) Agronomical and nutritional evaluation of quinoa seeds (Chenopodium quinoa Willd.) as an ingredient in bread formulations. J Cereal Sci 55:132–138. doi: 10.1016/j.jcs.2011.10.010 CrossRefGoogle Scholar
- 19.Drzewiecki J, Delgado-Licon E, Haruenkit R, Pawelzik E, Martin-Belloso O, Park Y-S, Jung S-T, Trakhtenberg S, Gorinstein S (2003) Identification and differences of total proteins and their soluble fractions in some pseudocereals based on electrophoretic patterns. J Agric Food Chem 51:7798–7804. doi: 10.1021/jf030322x CrossRefGoogle Scholar
- 23.Bergamo P, Maurano F, Mazzarella G, Iaquinto G, Vocca I, Rivelli AN, De Falco E, Gianfrani C, Rossi M (2011) Immunological evaluation of the alcohol-soluble protein fraction from gluten-free grains in relation to celiac disease. Mol Nutr Food Res 55:1266–1270. doi: 10.1002/mnfr.201100132 CrossRefGoogle Scholar
- 24.Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Norén O, Roepstorff P, Lundin KE, Sjöström H, Sollid LM (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713–717. doi: 10.1038/nm0698-713 CrossRefGoogle Scholar